HDAC2 deficiency and histone acetylation.
Ree
Anne Hansen
AH
Folkvord
Sigurd
S
Flatmark
Kjersti
K
D000107:Acetylation; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D045744:Cell Line, Tumor; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D045325:HCT116 Cells; D019073:HT29 Cells; D056464:Histone Deacetylase 2; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000235:genetics* / Q000378:metabolism; D006657:Histones / Q000378:metabolism*; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology / Q000627:therapeutic use; D012097:Repressor Proteins / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism
D000970:Antineoplastic Agents; D056572:Histone Deacetylase Inhibitors; D006657:Histones; D006877:Hydroxamic Acids; D012097:Repressor Proteins; C012589:trichostatin A; D056464:Histone Deacetylase 2; D006655:Histone Deacetylases